The Peach IV team will guide you to the perfect solution for your goals
Galderma premieres positive interim results demonstrating the efficacy of its Injectable Aesthetics portfolio in addressing facial volume loss as a result of medication-driven weight loss Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra and Restylane Lyft or Contour effectively improved the facial aesthetic appearance of patients experiencing medication-driven weight loss with associated facial volume loss 1 A six-month extension study is ongoing to capture the combined and sustained effects of these treatments over time Galderma is well-positioned to support patients specific needs in this area, given its unique expertise in dermatology, including aesthetics, and its individualized treatment approach developed in close collaboration with healthcare professionals Zug, Switzerland January 14, 2025 Galderma announces positive first results from a trial designed to explore the benefits of Restylane Lyft or Contour in combination with Sculptra in patients with medication-driven weight loss with associated facial volume loss
Relevant to appetite-associated signaling, insulinotropic pathway biology, gastric-emptying models, adipose-associated signaling, and energy-balance research
Studies focus on biochemical characterization and behavior within IGF-1 long arginine 3 analog research and growth factor pathway studies models
What doctors do know is that it tends to be genetic and is often associated with people who have dry skin
doi:10.1016/j.addr.2019.11.009 44
